Your browser doesn't support javascript.
loading
Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease.
Lenders, M; Oder, D; Nowak, A; Canaan-Kühl, S; Arash-Kaps, L; Drechsler, C; Schmitz, B; Nordbeck, P; Hennermann, J B; Kampmann, C; Reuter, S; Brand, S-M; Wanner, C; Brand, E.
Afiliación
  • Lenders M; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, University Hospital Muenster, Muenster, Germany.
  • Oder D; Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center (CHFC), Fabry Center for Interdisciplinary Therapy (FAZIT), University of Wuerzburg, Wuerzburg, Germany.
  • Nowak A; Department of Internal Medicine, University Hospital of Zurich and University of Zurich, Zurich, Switzerland.
  • Canaan-Kühl S; Department of Medicine, Division of Nephrology, Campus Virchow-Klinikum, University Hospital Charité, Berlin, Germany.
  • Arash-Kaps L; Villa Metabolica, Department for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Drechsler C; Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center (CHFC), Fabry Center for Interdisciplinary Therapy (FAZIT), University of Wuerzburg, Wuerzburg, Germany.
  • Schmitz B; Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, University Hospital Muenster, Muenster, Germany.
  • Nordbeck P; Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center (CHFC), Fabry Center for Interdisciplinary Therapy (FAZIT), University of Wuerzburg, Wuerzburg, Germany.
  • Hennermann JB; Villa Metabolica, Department for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Kampmann C; Villa Metabolica, Department for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Reuter S; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, University Hospital Muenster, Muenster, Germany.
  • Brand SM; Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, University Hospital Muenster, Muenster, Germany.
  • Wanner C; Department of Internal Medicine I, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center (CHFC), Fabry Center for Interdisciplinary Therapy (FAZIT), University of Wuerzburg, Wuerzburg, Germany.
  • Brand E; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, University Hospital Muenster, Muenster, Germany.
J Intern Med ; 282(3): 241-253, 2017 09.
Article en En | MEDLINE | ID: mdl-28682471

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Corazón / Trasplante de Riñón / Enfermedad de Fabry / Anticuerpos Neutralizantes / Terapia de Reemplazo Enzimático / Inmunosupresores Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Male / Middle aged Idioma: En Revista: J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Corazón / Trasplante de Riñón / Enfermedad de Fabry / Anticuerpos Neutralizantes / Terapia de Reemplazo Enzimático / Inmunosupresores Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Male / Middle aged Idioma: En Revista: J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2017 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido